This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Chongqing Genrix Biopharmaceutical Co., Ltd., Beijing Wisdomab Biotechnology Co., Ltd., Chongqing Genrix Biopharmaceutical Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Shunan Wan: Innovator in Biopharmaceuticals
Introduction
Shunan Wan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies. With a focus on advancing medical science, Wan holds 3 patents that showcase his expertise and dedication to improving healthcare.
Latest Patents
Among his latest patents is the "BCMA x CD3 T Bispecific Cell Engager," which highlights his work on bispecific antibodies. This invention, titled "Anti-CD3E/BCMA Bispecific Antibody and Use Thereof," represents a significant advancement in targeted cancer therapies. These patents reflect Wan's commitment to addressing critical medical challenges through innovative solutions.
Career Highlights
Shunan Wan has worked with Chongqing Genrix Biopharmaceutical Co., Ltd., where he has contributed to various projects aimed at developing cutting-edge treatments. His experience in the biopharmaceutical industry has equipped him with the knowledge and skills necessary to drive innovation in this vital field.
Collaborations
Throughout his career, Wan has collaborated with notable professionals, including Junjie Hu and Xiaobo Hao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Shunan Wan is a dedicated inventor whose contributions to biopharmaceuticals are noteworthy. His innovative patents and collaborative efforts position him as a key figure in advancing medical science. Through his work, Wan continues to inspire future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile